There are 410 resources available
119P - Prospective trial of immuno-(chemo)therapy (IO) prior to resection, definitive chemo-radiotherapy, or palliative therapy in patients with borderline resectable non-small cell lung cancer (NSCLC) including oligometastatic disease (KOMPASSneo)
Presenter: Martin Faehling
Session: Poster Display session
120P - Neoadjuvant immunochemotherapy of pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
Presenter: Yulong Chen
Session: Poster Display session
121P - Neoadjuvant sintilimab and anlotinib combined with chemotherapy for resectable NSCLC: A prospective, single arm, multicenter study
Presenter: Xiaolong Yan
Session: Poster Display session
122P - Comparison of the efficacy of neoadjuvant pembrolizumab vs sintilimab combination with chemotherapy in resectable lung cancer: A multicenter propensity score matching study
Presenter: Xiaolong Yan
Session: Poster Display session
123P - Second progression-free survival (PFS2) after first progression in patients receiving PACIFIC regimen: An exploratory analysis of the Blue Sky observational study
Presenter: Andrea Riccardo Filippi
Session: Poster Display session
124P - SPOTLIGHT real-world study: Outcomes with or without consolidation durvalumab (D) after chemoradiotherapy (CRT) in patients with unresectable stage III NSCLC
Presenter: Ryan Whitaker
Session: Poster Display session
125P - Real-world treatment patterns in stage III NSCLC patients: Interim results of a prospective, multicenter, non-interventional study (MOOREA)
Presenter: Ligang Xing
Session: Poster Display session
126P - Chemotherapy and stereotactic ablative radiotherapy in newly diagnosed and recurrent locally advanced non-small cell lung cancer patients unfit for concurrent radio-chemotherapy: Sub-analysis and update of START-NEW-ERA non-randomised phase II trial
Presenter: Fabio Arcidiacono
Session: Poster Display session
127P - Stereotactic ablative radiotherapy and durvalumab: The backbone of unresectable locally advanced non-small cell lung cancer patients unfit to concurrent chemo-radiotherapy – Rib of START-NEW-ERA trial
Presenter: Fabio Arcidiacono
Session: Poster Display session
128P - Stereotactic ablative radiotherapy in locally-advanced non-small cell lung cancer patients: Little palliation or big cure? Sub-analysis of START-NEW-ERA phase II trial
Presenter: Fabio Arcidiacono
Session: Poster Display session